ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Clinical trial NCT07173751 · RECRUITING

Trial details

NCT number: NCT07173751
Sponsor: BioNTech SE
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2025-10-30
Primary completion: 2029-12-01
Enrollment: 558

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.